Contact Information Existing patients Provided once accepted as a patient - this is physical office specific New patients NA - referral through physician is required Referrals Fax: 416 946 2900. No self-referrals accepted. All referrals must come from a physician. Financial liason Not needed. For drug reimbursement issues (if needed) both PMCC and MSH has separate teams that serve patients for this purpose. Designations and Memberships NCI Designated Comprehensive Cancer Center The Phase 1 Drug Development Team closely works with the sarcoma medical oncology team holds a UM-01 grant and is part of the ECTCN Membership NCI Experimental Therapeutics Clinical Trials Network (ETCTN) Sarcoma Faculty Medical Director Dr. Peter Ferguson peter.ferguson@sinalhealth.ca Nurse Director NA Administrative Director Ms. Jennifer Catton jennifer.catton@uhn.ca Surgeons 12 Medical Oncologists 2 Surgical Oncologists 3 Orthopedic Oncologists 3 Radiologists 4 Interventional Radiologists 2 Sarcoma Pathologists 3 Physicians Jay Wunder - Orthopedic Surgery Peter Ferguson - Orthopedic Surgery Kim Tsoi - Orthopedic Surgery Carol Swallow - GI Surgery Savtaj Brar - GI Surgery Rebecca Gladdy - GI Surgery Charles Catton - Radiation Oncology David Kirsch - Radiation Oncology Phillip Wong - Radiation Oncology David Shultz - Radiation Oncology Peter Chung - Radiation Oncology Abha Gupta - Medical Oncology Albiruni R. Abdul Razak, - Medical Oncology Geoffrey Watson - Medical Oncology Abdulazeez T. Salawu - Medical Oncology Brendan Dickson - Pathology Elizabeth Demicco - Pathology Linxing Zhang - Pathology Marcelo Cypel - Thoracic Surgery Elliot Wakeham - Thoracic Surgery Ezra Hahn - Head and Neck Radiation Oncology Ali Hosni - Head and Neck Radiation Oncology Jonathan Irish - ENT John De Almeida - ENT Ian Witterick - ENT Erik Monteiro - ENT Sarcoma Information New cases of sarcoma seen anually Over 100 Average number of sarcoma surgeries per year Over 100 Sarcoma clinical trials actively accruing patients in the past 12 months 12 Proton beam radiation therapy No Dedicated institutional sarcoma registry Yes Multi-disciplinary tumor board Yes Services Offered Telemedicine consultations Yes Sarcoma patient advocacy group Yes